Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Illumina

3 Biotech Stocks Investors Are Watching for Future Growth

A wide range of applications across several sectors, supportive government initiatives, rapid technological advancements, and shifting market dynamics position the biotechnology industry for robust long-term growth. Given the industry’s bright outlook, biotech stocks MannKind (MNKD), Illumina (ILMN), and TG Therapeutics (TGTX) could be ideal watchlist additions for potential growth. Read…

Stocks Settle Mixed as 10-Year T-note Yield Stays Above 4%

Stocks Settle Mixed as 10-Year T-note Yield Stays Above 4%

What you need to know… The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed down -0.15%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.42%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.17%. Stocks on Tuesday settled mixed. Reduced expectations for...

Stocks Fall Back after Monday’s Tech-Led Rally

Stocks Fall Back after Monday’s Tech-Led Rally

What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is down -0.42%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.70%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.36%. Stocks this morning are moderately lower as technology stocks...

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

12 Stocks Turn $10,000 Into $313,671 In 12 Months

Talk about a strong finish. Investors who hung onto the top S&P 500 stocks this year ended up much richer for the effort.

Investors Business Daily

Stocks Rise on Dovish Fed Comment

What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is up +0.41%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.36%. Stocks this morning are mildly higher, with the S&P...

Icahn Targets Illumina's Legacy Directors Removal

In a daring move, visionary investor Icahn seeks to oust Illumina's old guard, asserting fresh energy is needed in a vibrant, change-chasing letter.

Illumina Ends Its Controversial Grail Battle With A Divestiture; Shares Rise

Illumina stock rose Monday after the company said it would divest its cancer detection outfit, Grail, following a lengthy court battle.

Investors Business Daily

inkl

Read news from The Economist, FT, and more,
with one subscription

Illumina To Sell Grail After U.S. Antitrust Ruling

Illumina To Sell Grail After U.S. Antitrust Ruling

Illumina said Sunday it will the sell cancer detection startup after a U.S. appeals court said the $7.1 billion deal violated antitrust laws,

Investors Business Daily

Illumina Sheds Light, Divests its Cancer Tester, Grail

Illumina Sheds Light, Divests its Cancer Tester, Grail

Illumina, a beacon in genetic science, is set to unfurl its stake in Grail-the stellar creator of cancer-detecting tests–in a dance of corporate divestiture.

AI will live up to the hype and more unicorns will lose their horns: 10 health care predictions for 2024 from top investors

AI will live up to the hype and more unicorns will lose their horns: 10 health care predictions for 2024 from top investors

Top health care investors Bob Kocher and Bryan Roberts share their annual predictions for the sector–and how last year's list panned out.

DNA-Reading Giant Illumina Crashes As Macro Pressures Guidance — Again

DNA-Reading Giant Illumina Crashes As Macro Pressures Guidance — Again

Illumina stock crashed Friday after the DNA-reading behemoth slashed its outlook as pressures continue to build on life sciences companies.

Investors Business Daily

EU orders biotech giant Illumina to unwind $7.1 billion purchase of cancer-screening company Grail

EU orders biotech giant Illumina to unwind $7.1 billion purchase of cancer-screening company Grail

The European Union is ordering U.S. biotech giant Illumina to undo its $7.1 billion purchase of cancer-screening company Grail because it closed the deal without approval of regulators

The Independent UK

Dow Jones Futures Rise After Nasdaq, Nvidia Break Support In AI Sell-Off; Inflation Data Due

Dow Jones Futures Rise After Nasdaq, Nvidia Break Support In AI Sell-Off; Inflation Data Due

The Nasdaq and Nvidia fell below their 50-day moving averages, with AI stocks tumbling. Inflation data is on tap. Here's what to do now.

Investors Business Daily

Illumina Recovers After Torching Its 2023 Outlook; Announces A 'Huge Accomplishment'

Illumina Recovers After Torching Its 2023 Outlook; Announces A 'Huge Accomplishment'

Illumina stock recovered Thursday after the company torched its guidance on continuing headwinds. ILMN stock briefly retook its 50-day line.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Inside Illumina’s bruising proxy battle with billionaire activist investor Carl Icahn

Illumina’s contentious acquisition of cancer test maker Grail brought billionaire Carl Icahn to the company’s doorstep.

The Independent UK

EU fines US firm Illumina $475 million for jumping gun on buying cancer-screening company Grail

The European Union has slapped a $475 million fine on U.S. biotech giant Illumina for buying out cancer-screening company Grail without the approval of the 27-nation bloc’s antitrust watchdog

Cancer vaccines are already a reality. Here's what you need to know about the cutting-edge technology that could usher in an era of personalized medicine

The concept may seem torn from the plot of some futuristic sci-fi movie, or from the pages of some decades-old utopian novel far ahead of its time. But such wonders of science exist today.

Illumina’s Sudden CEO Exit Is Just One of Many Problems Facing DNA Company

The sudden resignation of Francis deSouza raises questions about the firm’s future after its proxy fight with Carl Icahn.

Get all your
news in one place.

100’s of premium titles.
One news app.

Primate genome study reveals evolutionary traits, human uniqueness and disease mutations

CCMB team, along with international scientists, conducted genome sequencing of 809 individuals from 233 primate species, covering nearly half of all existing primate species on earth

Studying Primates Sheds Light On Causes Of Common Diseases

Scientists mapped the DNA of over 800 individuals from 233 primate species.

Carl Icahn’s activist play plays into the hands of Lina Khan and EU regulators

Every company with acquisition plans in the U.S. and Europe should be concerned about the FTC partnering with EU regulators to sink the Illumina-Grail deal.

DNA sequencing platform hit by serious security flaws

One of the two vulnerabilities discovered carries a 10/10 severity score.

Investors Business Daily

Market Rally Wobbles Amid Big Earnings Moves From Microsoft, Meta, Crocs, Cloudflare: Weekly Review

The stock market rally went to "under pressure" amid big earnings moves and revived banking fears, but the major indexes ultimately closed tightly again.

Investors Business Daily

Dow Jones Reverses Lower As Microsoft Surges On Earnings; Tesla Stock Slides On Downgrade; Facebook Earnings Next

The Dow Jones rose Wednesday, as Microsoft surged on earnings. Tesla stock was downgraded. And Facebook earnings are next.

Investors Business Daily

Illumina Stock Tumbles As Sales, Profits Decline — Why The First-Quarter Beat Has 'Mixed Implications'

DNA-sequencing leader Illumina eked out a first-quarter beat, but ILMN stock toppled Wednesday on its cloudy future.

People

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

Intel Corporation

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

260,500 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play